NCT01325350View on ClinicalTrials.gov

Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss

PHASE2CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

September 30, 2012

Conditions
AlopeciaBaldness
Interventions
DRUG

bimatoprost Formulation A

Approximately one mL dose applied evenly onto pre-specified area on scalp, once daily for 6 months.

DRUG

bimatoprost Formulation B

Approximately one mL dose applied evenly onto pre-specified area on scalp, once daily for 6 months.

DRUG

bimatoprost Formulation C

Approximately one mL dose applied evenly onto pre-specified area on scalp, once daily for 6 months.

DRUG

bimatoprost vehicle solution

Approximately one mL dose applied evenly onto pre-specified area on scalp, once daily for 6 months.

DRUG

minoxidil 2% solution

Approximately one mL dose applied evenly onto pre-specified area on scalp, twice daily for 6 months.

Trial Locations (2)

Unknown

Portland

Berlin

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01325350 - Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss | Biotech Hunter | Biotech Hunter